Weekly Administration of Brodalumab in Hidradenitis Suppurativa: An Open Label Cohort Study
收藏官方服务：
资源简介：
Clinical Trial of Weekly Brodalumab in Hidradenitis Suppurativa
应用场景：
创建时间：
2020-06-20
相关数据集
Table_2_Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201).docx
BackgroundNearly all anti-PD-1 antibodies are of the IgG4 isotype, and thus possess residual FcR effector functions. Such anti-PD-1 antibodies are also associated with immune tolerance and escape due
NIAID Data Ecosystem70
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
The study will determine the recommended Phase 2 dose (RP2D) of livmoniplimab (ABBV-151) administered as monotherapy and in combination with budigalimab (ABBV-181) as well as to assess the safety, tol
NIAID Data Ecosystem30
Efficacy and Safety of Ruxolitinib Cream in Patients With Mild to Moderate Hidradenitis Suppurativa: Results From a Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study
Supplemental data for an article published in the Journal of the American Academy of Dermatology
NIAID Data Ecosystem20
Wide Local Excision is Non-inferior to Deroofing for Advanced Hidradenitis Suppurativa: A Retrospective Cohort Study
Supplemental Material - Wide Local Excision is Non-inferior to Deroofing for Advanced Hidradenitis Suppurativa: A Retrospective Cohort Study
DataCite Commons2026-03-31 更新30
Supplemental Data Lev-Tov H et al 2025
Supplemental Data for "Minimally Invasive Procedure for Hidradenitis Suppurativa Using Antimicrobial Wound Gel Resolves Tunnels, Reverses Microbial Dysbiosis, Decreases Inflammation, and Improves Qual
NIAID Data Ecosystem30
